About: Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

article

Attributes	Values
rdf:type	Item
description	article (en) wetenschappelijk artikel (nl) наукова стаття, опублікована у вересні 2010 (uk) im September 2010 veröffentlichter wissenschaftlicher Artikel (de)
publication date	wds:Q57955820-8A283CBD-4022-4786-984A-413FFA50BFF0
publication date	2010-09-16 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q57955820-0EDDABD3-70DF-434E-8CB6-2865B6AF953C
language of work or name	English
author name string	wds:Q57955820-0AAD5D40-C1F0-49A9-A0F1-3D2F1C51E883 wds:Q57955820-345AA2D0-055B-46ED-B953-C1DA13C7DF3B wds:Q57955820-5302C66A-A3FB-4002-9734-FE7B001777D6 wds:Q57955820-870A86F8-008E-4384-AF2D-19AD289E27D6 wds:Q57955820-A3DAF383-2C56-4C83-AAAF-72C6829B14D0 wds:Q57955820-A4096B5D-80C7-4C6A-B6FD-241B87C92918 wds:Q57955820-A41B86AF-71F4-4632-A23E-3B8786784858 wds:Q57955820-A77A5C1F-C539-41A5-A7CB-B316BDF0BF5C wds:Q57955820-A859A647-4CD2-4158-8E9D-BB569C2783BB wds:Q57955820-EB12BA16-1687-41D1-BFC4-4B8FE17F2624
author name string	Stephen Rennard Bruce Miller Peter Calverley Alvar Agusti Nicholas Locantore David A. Lomas Emiel F.M. Wouters John R. Hurst Hana Müllerova Jadwiga A. Wedzicha
rdfs:label	Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease (en) Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease (nl)
skos:prefLabel	Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease (en) Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease (nl)
name	Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease (en) Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease (nl)
author	wds:Q57955820-5CE5E395-6AAE-4E53-985D-DA32F4EE2321 wds:Q57955820-74563D86-1EFE-4FB0-9979-373E90D8C85A wds:Q57955820-89A875F8-08F7-47F9-AF71-A26A909FC583 wds:Q57955820-B057079D-AA50-45F6-AE85-B63034DF4132
author	William MacNee Antonio Anzueto Ruth Tal-Singer Jørgen Vestbo
title	wds:Q57955820-77C14F77-CF0A-498D-A373-BBFF28FEE32F
title	Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease (en)
page(s)	wds:Q57955820-8C46A6DB-757B-471B-A324-DDE29A430223
page(s)	1128-1138
instance of	wds:Q57955820-7415301C-030B-4574-A675-55D3F0879B67
instance of	scholarly article
main subject	wds:Q57955820-1188F384-0210-46E5-94C4-41C9E4062339
main subject	chronic obstructive pulmonary disease
PubMed ID	wds:Q57955820-1E6C0454-EEE7-4D19-AE9D-77E3817D2FFC
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/20843247
PubMed ID	20843247
published in	wds:Q57955820-4CC7BC0E-921C-46D7-B94A-C7F4219FC89E
published in	The New England Journal of Medicine
issue	wds:Q57955820-F38D258E-57FC-4A8A-8AC3-045FF65C62CA
volume	wds:Q57955820-98268F7E-9D23-4C3E-A38B-4374E741524E
issue	12
volume	363
DOI	wds:Q57955820-898DF41E-4902-4133-BFD4-61708E10C141
DOI	http://dx.doi.org/10.1056/NEJMOA0909883
DOI	10.1056/NEJMOA0909883
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q57955820
is cites work of	Exacerbation frequency and course of COPD. The role of bronchodilator treatment in the prevention of exacerbations of COPD. An update on bronchodilators in Phase I and II clinical trials Chronic obstructive pulmonary disease Acute mechanical forces cause deterioration in lung structure and function in elastase-induced emphysema Evaluating the role of inflammation in chronic airways disease: the ERICA study The clinical and genetic features of COPD-asthma overlap syndrome Challenges of COPD diagnosis A new approach to grading and treating COPD based on clinical phenotypes: summary of the Spanish COPD guidelines (GesEPOC). Virus-induced exacerbations in asthma and COPD Peripheral blood mononuclear cell gene expression in chronic obstructive pulmonary disease Efficacy and safety of a fixed-dose combination of mometasone furoate and formoterol fumarate in subjects with moderate to very severe COPD: results from a 52-week Phase III trial Influence of changes in physical activity on frequency of hospitalization in chronic obstructive pulmonary disease. Subtypes of patients experiencing exacerbations of COPD and associations with outcomes Protection against Streptococcus pneumoniae lung infection after nasopharyngeal colonization requires both humoral and cellular immune responses Procalcitonin and C-reactive protein cannot differentiate bacterial or viral infection in COPD exacerbation requiring emergency department visits Emphysema distribution and annual changes in pulmonary function in male patients with chronic obstructive pulmonary disease Effect of β blockers on mortality after myocardial infarction in adults with COPD: population based cohort study of UK electronic healthcare records Simvastatin for the prevention of exacerbations in moderate-to-severe COPD Disproportionate utilization of healthcare resources among veterans with COPD: a retrospective analysis of factors associated with COPD healthcare cost Predictors of ICS/LABA prescribing in COPD patients: a study from general practice The effect of real-time teleconsultations between hospital-based nurses and patients with severe COPD discharged after an exacerbation Soluble receptor for advanced glycation end products in COPD: relationship with emphysema and chronic cor pulmonale: a case-control study Cluster analysis in the COPDGene study identifies subtypes of smokers with distinct patterns of airway disease and emphysema Risk factors and early origins of chronic obstructive pulmonary disease Reproducibility and respiratory function correlates of exhaled breath fingerprint in chronic obstructive pulmonary disease Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype Chronic obstructive pulmonary disease exacerbations in the COPDGene study: associated radiologic phenotypes The lung tissue microbiome in chronic obstructive pulmonary disease Blood fibrinogen as a biomarker of chronic obstructive pulmonary disease Personalizing and targeting therapy for COPD: the role of molecular and clinical biomarkers. Lessons from ECLIPSE: a review of COPD biomarkers Should we view chronic obstructive pulmonary disease differently after ECLIPSE? A clinical perspective from the study team. Dual therapy strategies for COPD: the scientific rationale for LAMA + LABA Host Response to the Lung Microbiome in Chronic Obstructive Pulmonary Disease Rhinovirus infection induces degradation of antimicrobial peptides and secondary bacterial infection in chronic obstructive pulmonary disease

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software